SCHEMBL5250885

SCHEMBL5250885

[O-][n+]1c(-c2ccccc2)ncc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
BCL2 P10415 1/20 0.37
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
LMNA P02545 3/20 0.32
MAPT P10636 3/20 0.32
RECQL P46063 1/20 0.32
GAA P10253 2/20 0.31
CACNA1B Q00975 2/20 0.31
APBA1 Q02410 2/20 0.31
GPR3 P46089 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3111168 0.76 ATM (0.40) ATMKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL8424490 0.73 ATM (0.48) ATMNPC1RAB9AKDM4EGPR3
SCHEMBL3535166 0.73 ATM (0.48) ATMNPC1RAB9AKDM4EMAPT
SCHEMBL4620642 0.73 ATM (0.48) ATMNPC1RAB9ABCL2KDM4E
SCHEMBL4559941 0.73 ATM (0.48) ATMNPC1RAB9AKDM4EGPR3
SCHEMBL5259264 0.73 ATM (0.48) ATMNPC1RAB9AKDM4EGPR3
SCHEMBL6557052 0.72 ATM (0.36) ATMKDM4EGPR3
SCHEMBL9769252 0.70 ATM (0.45) ATMNPC1RAB9AKDM4EGPR3
SCHEMBL8423013 0.69 ATM (0.44) ATMNPC1RAB9ACYP1A2CYP2A6
SCHEMBL9769436 0.69 ATM (0.44) ATMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563272-B Preparation method of 2-phenylquinazolinone compound 三峡大学 2023-03-10 CN claimed
CN-113563272-A Preparation method of 2-phenylquinazolinone compound 三峡大学 2021-10-29 CN claimed
CN-108033919-B Method for synthesizing 2-phenyl quinazolinone compound by taking styrene compound as raw material 温州大学 2021-03-02 CN claimed
CN-108129402-B Method for synthesizing 2-phenyl quinazolinone compound by taking tolane compound as raw material 温州大学 2021-02-12 CN claimed
CN-116444444-A Method for preparing 2-substituted quinazolinone compound 盐城工业职业技术学院 2023-07-18 CN disclosed
CN-113563272-B Preparation method of 2-phenylquinazolinone compound 三峡大学 2023-03-10 CN disclosed
CN-113563272-B Preparation method of 2-phenylquinazolinone compound 三峡大学 2023-03-10 CN disclosed
CN-113563272-B Preparation method of 2-phenylquinazolinone compound 三峡大学 2023-03-10 CN disclosed
CN-112125900-B Synthetic method of isoquinolino-quinazolinone compound 常州工程职业技术学院 2022-11-18 CN disclosed
CN-112958162-B Palladium catalyst for catalyzing quinazolinone synthesis and olefination reaction 江南大学 2022-05-24 CN disclosed
CN-113563272-A Preparation method of 2-phenylquinazolinone compound 三峡大学 2021-10-29 CN disclosed
CN-113563272-A Preparation method of 2-phenylquinazolinone compound 三峡大学 2021-10-29 CN disclosed
EP-1696927-A2 MITOTIC KINESIN INHIBITORS Merck & Co., Inc. (US) 2006-09-06 EP disclosed
WO-2005065183-A2 MITOTIC KINESIN INHIBITORS MERCK & CO., INC. (US) 2005-07-21 WO disclosed
CN-1476435-A Fluorinated quinolones as antimitotic and antitumor agents 北卡罗来纳查佩尔山大学 2004-02-18 CN disclosed
EP-1322615-A2 FLUORINATED QUINOLONES AS ANTIMITOTIC AND ANTITUMOR AGENTS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2003-07-02 EP disclosed
US-6569870-B1 Anticarcinogenic agents for breast and ovarian cancer THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2003-05-27 US disclosed
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
WO-2002026730-A2 FLUORINATED QUINOLONES AS ANTIMITOTIC AND ANTITUMOR AGENTS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2002-04-04 WO disclosed